AEterna Zentaris Inc (AEZS.O)

AEZS.O on Consolidated Issue listed on NASDAQ Capital Market

1.17USD
24 Apr 2014
Price Change (% chg)

$0.02 (+1.74%)
Prev Close
$1.15
Open
$1.16
Day's High
$1.18
Day's Low
$1.16
Volume
93,433
Avg. Vol
1,041,059
52-wk High
$2.18
52-wk Low
$0.99

AEZS.O

Chart for AEZS.O

About

Aeterna Zentaris Inc. is a late-stage drug development company specialized in oncology and endocrine therapy. The Company’s pipeline encompasses compounds at all stages of development, from drug discovery through to marketed products. The development priorities in oncology are the completion of Phase 3 trials with perifosine in... (more)

Overall

Beta: 1.83
Market Cap (Mil.): $64.60
Shares Outstanding (Mil.): 56.51
Dividend: --
Yield (%): --

Financials

  AEZS.O Industry Sector
P/E (TTM): -- 26.72 33.52
EPS (TTM): -0.78 -- --
ROI: -52.43 -2.70 18.94
ROE: -525.41 -11.99 19.71
Search Stocks

BRIEF-AEterna Zentaris U.S.-listed shares down 21.2 percent premarket

NEW YORK, Jan 9 - AEterna Zentaris Inc : * U.S.-listed shares down 21.2 percent to $1.15 in premarket; prices $13.2 million public offering of common shares and warrants

09 Jan 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: S&P Capital IQ Quantitative Report
$127.00
Provider: Reuters Investment Profile
$20.00
Provider: Pechala's Reports
$15.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks